|
2003 Conference Publication Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated deliveryMarano, R. J., Wimmer, N., Kearns, P. S., Thomas, B. G., Toth, I., Wilson, A. S., Brankov, M. and Rakoczy, P. E. (2003). Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated delivery. 3rd Meeting of the Australasian-Gene-Therapy-Society, Brisbane Australia, Apr 30-May 02, 2003. CHICHESTER: Wiley. |
|
2003 Conference Publication Liposaccharide delivery system: Application for peptide IT-100, LHRH and conotoxin MIIBlanchfield, J. T., Chan, Y., Rhee, H., Alewood, P.F., Adams, D. J. and Toth, I. (2003). Liposaccharide delivery system: Application for peptide IT-100, LHRH and conotoxin MII. 18th American Peptide Symposium, Boston, USA, 19-23 July, 2003. HOBOKEN: JOHN WILEY & SONS INC. |
|
2003 Conference Publication Liposacchride delivery system: Application to peptides conotoxin MII and endomorphin IBlanchfield, J. T., Gallagher, O. P., Koda, Y. and Toth, I. (2003). Liposacchride delivery system: Application to peptides conotoxin MII and endomorphin I. Brisbane Biological and Organic Chemistry Symposium, Gold Coast, 28 Nov, 2003. |
|
2002 Conference Publication Reactions of carbohydrate tosylates and mesylates with nucleophiles: Control of inversions of stereochemistryToth, I., McGeary, R. P. and Tang, V.W.S. (2002). Reactions of carbohydrate tosylates and mesylates with nucleophiles: Control of inversions of stereochemistry. XX1st International Carbohydrate Symposium, Cairns, 7-12 July 2002. |
|
2002 Conference Publication Lipid-core-peptides for vaccination: Structure-activity relationshipToth, I., Horvath, A., McGeary, R. P., Hayman, W. A., Olive, C. and Good, M. F. (2002). Lipid-core-peptides for vaccination: Structure-activity relationship. 27th European Peptide Symposium, Sorrento, Italy, 31 Aug. - 6 Sept. 2002. Napoli, Italy: Edizioni Ziino. |
|
2002 Conference Publication Modify the bioactive to increase the availability and potency of a drug: Lipids and sugars in drug delivery and vaccine developmentBlanchfield, J. T. and Toth, I. (2002). Modify the bioactive to increase the availability and potency of a drug: Lipids and sugars in drug delivery and vaccine development. 8th International Pacific Rim Biotechnology Conference, Auckland, NZ, 17-20 Nov. 2002. |
|
2002 Conference Publication A novel immunoadjuvant carrier system for synthetic peptidesHorvath, A., Olive, C., Good, M. F. and Toth, I. (2002). A novel immunoadjuvant carrier system for synthetic peptides. 27th European Peptide Symposium, Sorrento, Italy, 31 Aug. - 6 Sept. 2002. Napoli, Italy: E. Ziino. |
|
2002 Conference Publication Liposaccharides in drug deliveryToth, I., Blanchfield, J. T., McGeary, R. P., Ross, B. P. and Chan, Y. (2002). Liposaccharides in drug delivery. XX1st International Carbohydrate Symposium, Cairns, 7-12 July 2002. |
|
2001 Conference Publication Towards synthetic vaccines built on carbohydrate coresMcGeary, Ross P., Jablonkai, Istvan and Toth, Istvan (2001). Towards synthetic vaccines built on carbohydrate cores. Netherlands: Springer. doi: 10.1023/A:1016212726860 |
|
2001 Conference Publication Lipid-core-peptides for vaccination: A structure-activity relationship study.Olive, C., Schubert, A., Wong, A. K., Good, M. F. and Toth, I. (2001). Lipid-core-peptides for vaccination: A structure-activity relationship study.. 4th Australian Peptide Conference, Lindeman Island, Qld., 7-12 Oct 2001. |
|
2001 Conference Publication Synthetic vaccines built on carbohydrate coresMcgeary, R. P. and Toth, I. (2001). Synthetic vaccines built on carbohydrate cores. 4th Australian Peptide Conference, Lindeman Is., Qld, 7-12 Oct 2001. Australian Peptide Society. |
|
2001 Conference Publication Solid-phase synthesis of oligosaccharides utilising a novel Dde-based linkerMoyle, P.M., Mcgeary, R. P. and Toth, I. (2001). Solid-phase synthesis of oligosaccharides utilising a novel Dde-based linker. APSA Annual Conference 2001, Melbourne, 9-12 Dec 2001. Melbourne: Australasian Pharmaceutical Science Association. |
|
2001 Conference Publication The synthesis and biological activity of an orally available liposaccharide analogue of LHRH.Blanchfield, J. T., Rhee, H. and Toth, I. (2001). The synthesis and biological activity of an orally available liposaccharide analogue of LHRH.. APSA Annual Conference 2001, Melbourne, 9-12 Dec 2001. Melbourne: Australasian Pharmaceutical Science Association. |
|
2001 Conference Publication The synthesis and biological activity of an orally available liposaccharide analogue of LHRH.Blanchfield, J. T., Rhee, H. and Toth, I. (2001). The synthesis and biological activity of an orally available liposaccharide analogue of LHRH.. Brisbane Biological & Organic Chemistry Symposium 2001, University of Queensland, Brisbane, 30 Nov 2001. Brisbane: |
|
2001 Conference Publication Glycolipid-modified peptides: Enhancement of absorption of an anti-tumour somatostatin analogueMalkinson, J. P., Lazorova, L., Artursson, P., Keri, G. and Toth, I. (2001). Glycolipid-modified peptides: Enhancement of absorption of an anti-tumour somatostatin analogue. 26th European Peptide Conference, Montpellier, France, 10-15 Sept 2000. Paris, France: EDK. |
|
2001 Conference Publication Enhanced immunogenicity of group A streptococcal peptide epitopes by lipoamino acid based adjuvant carrier system.Schubert, A., Olive, C., Wong, A. K., Good, M. F. and Toth, I. (2001). Enhanced immunogenicity of group A streptococcal peptide epitopes by lipoamino acid based adjuvant carrier system.. APSA Annual Conference 2001, Melbourne, 9-12 Dec 2001. Melbourne: Australasian Pharmaceutical Science Association. |
|
2001 Conference Publication Allosamines and galactosamines from glucosamine: Control of stereochemical inversions at C-3 and C-4.Mcgeary, R. P., Wright, K. and Toth, I. (2001). Allosamines and galactosamines from glucosamine: Control of stereochemical inversions at C-3 and C-4.. Brisbane Biological and Organic Chemistry Symposium 2001, UQ, Brisbane, 30 Nov 2001. Brisbane: |
|
2001 Conference Publication Enhancing peptide delivery using lipoamino acids and liposaccharides.Mcgeary, R. P., Blanchfield, J. T., Rhee, H., Alewood, P.F. and Toth, I. (2001). Enhancing peptide delivery using lipoamino acids and liposaccharides.. 7th International Symposium on Solid Phase Synthesis & Combinatorial Chemical Libraries, Southampton, UK, 18-22 Sept 2001. UK: European Peptide Society & BS/RSC Protein & Peptide Group, UK. |
|
2001 Conference Publication Liposaccharides: Utilisation for peptide delivery and for enhancing synthetic peptide immunogenicity.Toth, I., Mcgeary, R. P., Blanchfield, J. T., Rhee, H., Alewood, P. F., Adams, D. J. and Good, M. F. (2001). Liposaccharides: Utilisation for peptide delivery and for enhancing synthetic peptide immunogenicity.. 2nd International & 17th American Peptide Symposium, San Diego, California, US, 9-14 June, 2001. San Diego, CA: American Peptide Society. |
|
2001 Conference Publication Synthesis of cationic lipidic peptide dendrimer vectors for in vitro oligonucleotide delivery.Kearns, P. S., Wimmer, N., Rakoczy, P. E. and Toth, I. (2001). Synthesis of cationic lipidic peptide dendrimer vectors for in vitro oligonucleotide delivery.. APSA Annual Conference 2001, Melbourne, 9-12 Dec 2001. Melbourne: Australasian Pharmaceutical Science Association. |
